000			02008 a2200529 4500
005			20250516162408.0
264		0	_c20131112
008			201311s 0 0 eng d
022			_a1432-1335
024	7		_a10.1007/s00432-013-1476-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aEsparza-López, José
245	0	0	_aDoxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells. _h[electronic resource]
260			_bJournal of cancer research and clinical oncology _cOct 2013
300			_a1625-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntibiotics, Antineoplastic _xpharmacology
650	0	4	_aBenzamides _xpharmacology
650	0	4	_aCell Death _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDoxorubicin _xpharmacology
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aI-kappa B Proteins _xmetabolism
650	0	4	_aImatinib Mesylate
650	0	4	_aKinetics
650	0	4	_aNF-KappaB Inhibitor alpha
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aProtein Binding
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProtein Processing, Post-Translational _xdrug effects
650	0	4	_aProteolysis
650	0	4	_aProto-Oncogene Proteins c-abl _xantagonists & inhibitors
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aTranscriptional Activation _xdrug effects
700	1		_aMedina-Franco, Heriberto
700	1		_aEscobar-Arriaga, Elizabeth
700	1		_aLeón-Rodríguez, Eucario
700	1		_aZentella-Dehesa, Alejandro
700	1		_aIbarra-Sánchez, María J
773	0		_tJournal of cancer research and clinical oncology _gvol. 139 _gno. 10 _gp. 1625-35
856	4	0	_uhttps://doi.org/10.1007/s00432-013-1476-3 _zAvailable from publisher's website
999			_c22953546 _d22953546